Enovis (ENOV) Share-based Compensation Growth (3y) (2013 - 2026)
Enovis (ENOV) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.40% |
| 10 | Enovis | 1.51 Bn | 1.50 Bn | 359.25 Mn | -17.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | -17.79% |
| Apr 3, 2026 | 118.57% |
| Dec 31, 2025 | 53.23% |
| Oct 3, 2025 | -58.84% |
| Jul 4, 2025 | 8.32% |
| Apr 4, 2025 | -29.55% |
| Dec 31, 2024 | 26.64% |
| Sep 27, 2024 | -32.39% |
| Jun 28, 2024 | 121.75% |
| Mar 29, 2024 | -15.13% |
| Jun 30, 2023 | -28.01% |
| Mar 31, 2023 | -48.47% |
| Dec 31, 2022 | -17.80% |
| Sep 30, 2022 | 11.11% |
| Jul 1, 2022 | 18.77% |
| Apr 1, 2022 | 23.46% |
| Dec 31, 2021 | -248.00% |
| Oct 1, 2021 | 254.36% |
| Jul 2, 2021 | 9.31% |
| Apr 2, 2021 | 11.74% |